General Information
Revision date
2016-10-13
Product name
VisuCon™-L Coag Screen N, VisuCon™-L Coag Screen ABN1, VisuCon™-L Coag Screen ABN2, VisuCon™-L Normal Control Plasma, VisuCon™-L Abnormal Control Plasma
1.2.1 Relevant identified uses
For in vitro diagnostic use
supplier name
Affinity Biologicals Inc
Emergency telephone
905-304-9896 (EST 8 30 a.m. – 5 00 p.m.
Icons in SDS
Company Information
company name
Affinity Biologicals Inc
Section 2
SECTION 2: Hazards identification
POSSIBLE BIOHAZARD. Although this material was prepared with plasma collected from donors screened for CJD and which was tested at source and found negative for HBsAg, syphilis and antibodies to HIV and HCV and non-reactive for HIV-1 rNA and HCV rNA by FDA approved tests, it should be handled by personnel trained in the proper procedures for handling potential viral contaminants. All wastes should be properly labeled and disposed of according to all international, national and local regulations.
